EMCOR Group, Inc. (EME) Reaches $84.14 52-Week High; 1 Analysts Covering aTyr Pharma, Inc. (LIFE)

January 14, 2018 - By Stephen Andrade

Among 7 analysts covering Life Technologies Corp (NASDAQ:LIFE), 1 have Buy rating, 1 Sell and 5 Hold. Therefore 14% are positive. Life Technologies Corp had 11 analyst reports since August 25, 2015 according to SRatingsIntel. Piper Jaffray initiated the shares of LIFE in report on Thursday, September 7 with “Buy” rating. On Thursday, March 31 the stock rating was downgraded by William Blair to “Market Perform”. On Thursday, September 17 the stock rating was downgraded by Zacks to “Sell”. The rating was maintained by BMO Capital Markets with “Hold” on Wednesday, November 1. The stock of aTyr Pharma, Inc. (NASDAQ:LIFE) earned “Hold” rating by BMO Capital Markets on Monday, August 14. The stock of aTyr Pharma, Inc. (NASDAQ:LIFE) earned “Hold” rating by Zacks on Tuesday, August 25. Citigroup maintained aTyr Pharma, Inc. (NASDAQ:LIFE) on Tuesday, August 16 with “Neutral” rating. JP Morgan downgraded the stock to “Neutral” rating in Wednesday, December 14 report. The firm has “Overweight” rating by JP Morgan given on Thursday, August 11. The firm earned “Neutral” rating on Wednesday, December 16 by Citigroup. See aTyr Pharma, Inc. (NASDAQ:LIFE) latest ratings:

14/11/2017 Broker: J.P. Morgan Rating: Hold
01/11/2017 Broker: BMO Capital Markets Rating: Hold New Target: $4.0 Maintain
07/09/2017 Broker: Piper Jaffray Rating: Buy New Target: $7.0 Initiate
14/08/2017 Broker: BMO Capital Markets Rating: Hold New Target: $4.0000 Maintain

The stock of EMCOR Group, Inc. (NYSE:EME) hit a new 52-week high and has $88.35 target or 5.00% above today’s $84.14 share price. The 9 months bullish chart indicates low risk for the $4.95 billion company. The 1-year high was reported on Jan, 14 by Barchart.com. If the $88.35 price target is reached, the company will be worth $247.45 million more. The stock increased 1.09% or $0.91 during the last trading session, reaching $84.14. About 176,716 shares traded. EMCOR Group, Inc. (NYSE:EME) has risen 40.80% since January 14, 2017 and is uptrending. It has outperformed by 24.10% the S&P500.

The stock decreased 1.27% or $0.05 during the last trading session, reaching $3.9. About 62,842 shares traded or 13.14% up from the average. aTyr Pharma, Inc. (NASDAQ:LIFE) has risen 12.96% since January 14, 2017 and is uptrending. It has underperformed by 3.74% the S&P500.

aTyr Pharma, Inc., a clinical stage biotherapeutics company, engages in the discovery and development of Physiocrine therapeutics for patients suffering from severe and rare diseases. The company has market cap of $116.06 million. The firm develops Resolaris, which is in Phase Ib/II clinical trials for treating patients with facioscapulohumeral muscular dystrophy , early onset FSHD, and limb-girdle muscular dystrophy, as well as under evaluation to treat Duchenne muscular dystrophy. It currently has negative earnings. The Company’s discovery program includes Stalaris for treating interstitial lung disease with an immune component; and preclinical research program comprises Project ORCA to treat therapeutic applications of Physiocrines.

Analysts await EMCOR Group, Inc. (NYSE:EME) to report earnings on February, 22. They expect $0.86 EPS, up 19.44% or $0.14 from last year’s $0.72 per share. EME’s profit will be $50.58 million for 24.46 P/E if the $0.86 EPS becomes a reality. After $1.09 actual EPS reported by EMCOR Group, Inc. for the previous quarter, Wall Street now forecasts -21.10% negative EPS growth.

EMCOR Group, Inc. provides electrical and mechanical construction, and facilities services in the United States. The company has market cap of $4.95 billion. The firm designs, integrates, installs, starts-up, operates, and maintains electric power transmission and distribution systems; premises electrical and lighting systems; process instrumentation in the refining, chemical process, food process, and mining industries; low-voltage, voice and data communications, fire protection, water and wastewater treatment, and controls and filtration systems; roadway and transit lighting and fiber-optic lines; heating, ventilation, air conditioning, refrigeration, and clean-room process ventilation systems; plumbing, processing, and piping systems; central plant heating and cooling systems; cranes and rigging; millwrighting; and steel fabrication, erection, and welding. It has a 23.52 P/E ratio. It also offers building services to facilities, such as commercial and government site activities and maintenance; reception, security, and catering; outage services to utilities and industrial plants; military base activities support; mobile mechanical maintenance and services; floor care and janitorial; landscaping, lot sweeping, and snow removal; facilities and vendor management; call center; installation and support for building systems; technical consulting and diagnostics; small modification and retrofit; infrastructure and building projects; and program development, management, and maintenance services for energy systems.

Investors sentiment increased to 1.34 in 2017 Q3. Its up 0.22, from 1.12 in 2017Q2. It improved, as 16 investors sold EMCOR Group, Inc. shares while 90 reduced holdings. 35 funds opened positions while 107 raised stakes. 53.99 million shares or 0.01% more from 53.99 million shares in 2017Q2 were reported. Advsr Asset Mngmt Incorporated reported 0.09% of its portfolio in EMCOR Group, Inc. (NYSE:EME). Legal General Grp Inc Public Ltd Company holds 79,052 shares. Moreover, Hbk Ltd Partnership has 0.05% invested in EMCOR Group, Inc. (NYSE:EME). Farmers And Merchants Invs Inc, Nebraska-based fund reported 257 shares. Staley Cap Advisers holds 0.03% or 5,190 shares. Fiera Corporation reported 788,519 shares. Franklin Res owns 649,810 shares or 0.02% of their US portfolio. Numeric Invsts Ltd Company owns 19,400 shares. Tci Wealth has 10 shares for 0% of their portfolio. Goldman Sachs Grp Inc Inc holds 0.02% or 1.19M shares. Train Babcock Advsr Limited Liability Co reported 1.69% stake. First Citizens Retail Bank And Tru reported 0.06% in EMCOR Group, Inc. (NYSE:EME). Huntington National Bank & Trust stated it has 527 shares. Daiwa Securities Gp has invested 0.03% in EMCOR Group, Inc. (NYSE:EME). Diligent Invsts Limited holds 0.48% of its portfolio in EMCOR Group, Inc. (NYSE:EME) for 9,400 shares.

Among 4 analysts covering EMCOR Group (NYSE:EME), 1 have Buy rating, 0 Sell and 3 Hold. Therefore 25% are positive. EMCOR Group had 15 analyst reports since October 14, 2015 according to SRatingsIntel. The firm has “Buy” rating by Stifel Nicolaus given on Tuesday, January 5. The rating was downgraded by DA Davidson to “Neutral” on Friday, February 26. Stifel Nicolaus upgraded EMCOR Group, Inc. (NYSE:EME) on Friday, February 24 to “Buy” rating. As per Wednesday, July 5, the company rating was maintained by Stifel Nicolaus. The firm has “Buy” rating by Stifel Nicolaus given on Tuesday, October 31. The rating was maintained by Stifel Nicolaus on Wednesday, September 20 with “Buy”. The stock of EMCOR Group, Inc. (NYSE:EME) has “Buy” rating given on Friday, October 28 by Stifel Nicolaus. The company was maintained on Tuesday, August 22 by KeyBanc Capital Markets. Stifel Nicolaus maintained EMCOR Group, Inc. (NYSE:EME) rating on Monday, May 2. Stifel Nicolaus has “Buy” rating and $57 target. Stifel Nicolaus downgraded it to “Hold” rating and $70 target in Thursday, December 8 report.

Since October 27, 2017, it had 0 insider purchases, and 1 insider sale for $1.01 million activity. RYAN JERRY E sold $1.01 million worth of stock or 13,000 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: